Surgical Glue Market is segmented By Product Type (Endosteal Implants, Subperiosteal Implants, Transosteal Implants, Intramucosal Implants), By Application (Titanium Implants, Zirconium Implants, Ceramic Implants, Porcelain Fused To the Metal Implants), By End-User (Hospitals, Dental Clinics, Academic & Research Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Surgical Glue Market Size
The Global Surgical Glue Market reached USD 2,542.40 million in 2022 and is projected to witness lucrative growth by reaching up to USD 4,683.76 million by 2030. The market is expected to exhibit a CAGR of 8.1% during the forecast period (2023-2030). Surgical glue, also called tissue adhesive or liquid stitches, is used to close both major and minor wounds such as lacerations, incisions made during laparoscopic surgery, wounds on the face or in the groin, and others. Surgical glue is applied as a liquid or pastes to the edges of the wound
Surgical Glue Market Scope
Metrics |
Details |
CAGR |
8.1% |
Size Available for Years |
2021-2030 |
Forecast Period |
2023-2030 |
Data Availability |
Value (US$) |
Segments Covered |
Product Type, Application, End User and Region |
Regions Covered |
North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
Fastest Growing Region |
Asia-Pacific |
Largest Region |
North America |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Orthopedic Surgery key Insights. |
For More Insights Request Free Sample
Surgical Glue Market Growth and Trends
The rise in the number of surgical procedures is boosting the global surgical glue market growth.
The rise in the number of surgical procedures performed is expected to drive the growth of the market. Synthetic and semi-synthetic glue is usually preferred by patients due to its cost-effectiveness and better adhesion as compared to others. As per the Association for Safe International Road Travel (ASIRT), approximately 1.3 million people die globally in road crashes each year; on an average, 3,700 people lose their lives every day on the roads. An additional 20–50 million suffer from non-fatal injuries, often resulting in long-term disabilities. Therefore, the rising cases of accidents result in high surgical procedures.
In Europe, the rate of surgical procedures is increasing. For instance, as per Eurostat, at least 1.12 million cesarean sections were performed in the EU in 2020. In 2020, transluminal coronary angioplasties were most common (relative to population size) in Croatia and Germany, where it was performed on average 462 and 384 times per 100,000 inhabitants, respectively. They were conducted between 150 and 329 times per 100,000 inhabitants in most of the remaining Member States for which data are available, with Portugal, Spain, Luxembourg, and Romania below this range.
Therefore, the rising number of surgeries performed is expected to drive the global market growth over the forecast period.
The limitations associated with surgical glue are hampering the growth of the global surgical glue market.
For instance, currently, there are no clinically approved surgical glues that are non-toxic, bind strongly to tissue, and work well within wet and highly dynamic environments within the body. Technologies for sealing or attaching devices to tissues without tissue penetration or compression exhibit major limitations, and this has been a barrier to the development of less invasive procedures. Thus, these limitations of surgical glues are hampering the global market growth.
Surgical Glue Market Segmentation Analysis
The global surgical glue market is segmented based on product type, application, end users, and region.
The cyanoacrylates segment is expected to hold dominant position in the market over the forecast period.
Cyanoacrylate (CA) and its homologs have a variety of medical and commercial applications as biological adhesives and sealants. Homologs of cyanoacrylate (CA) are being widely promoted in surgery as a tissue adhesive to replace traditional suturing techniques. Potential benefits of using CA adhesives include better cosmetic results, more rapid wound closure, and most significantly, the potential for significant reductions in percutaneous injuries from suture needles, which would in turn also reduce the risk of transmission of infectious diseases.
For instance, with its octyl-based cyanoacrylate formulation, the LiquiBand XL system provides safe, secure, and effective closure for large and high-tension wounds. LiquiBand XL has several advantages, including durable and effective wound closure for up to 14 days, consistent dry time in as little as 60 seconds, and an effective microbial barrier against gram-positive, gram-negative, and fungal microbes for at least seven days.
Similarly, DERMABOND Topical Skin Adhesive is a sterile, liquid topical skin adhesive containing a monomeric 2-octyl cyanoacrylate formulation. It is intended for topical application to hold closely approximated skin edges of wounds from surgical incisions, including punctures from minimally invasive surgery, and simple, thoroughly cleansed, trauma-induced lacerations.
These factors are expected to drive the cyanoacrylates segment growth in the global market over the forecast period.
Source: DataM Intelligence Analysis (2023)
Surgical Glue Market Geographical Share
North America holds dominant position in the global surgical glue market.
North America holds dominant position in the global surgical glue market and is expected to retain its position during the forecast period. The factors contributing to the growth include the increasing investments in the R&D of medical adhesives, growing developments, and the presence of a large number of medical schools and their several applications in different surgeries performed in the region. Heart Disease & Stroke Statistical Fact Sheet 2020 estimates that a minimum of 40,000 infants are expected to be affected each year by congenital heart defects in the U.S. Out of these, around 25%, or 2.4 (per 1,000 live births), actually require treatment in the first year of life.
Moreover, the increasing demand for and focus on cosmetic surgery and its growing awareness of preventative and corrective treatment in the U.S. are driving the growth of the market in this region. On May 25, 2022, LiquiBand XL, a novel device that heals large wounds than existing LiquiBand products, gained FDA 510(k) approval, according to Advanced Medical Solutions Group plc, the world's foremost expert in tissue-healing technology. The system consists of surgical mesh for wound closure and LiquiBand adhesive for securing the closure and preventing infection.
Source: DataM Intelligence Analysis (2023)
Surgical Glue Market Companies
The major global players in the market include B. Braun SE, Baxter, Advanced Medical Solutions Group plc, BD, Cardinal Health, Artivion, Inc. (Formerly CryoLife, Inc.), Medtronic PLC., Johnson & Johnson, Integra Lifesciences Holdings Corporation, and Vivostat A/S.
Key Developments
- In August 2022, TRB Chemedica UK, a market-leading pharma and biotechnology corporation based in Switzerland, announced a new sales and marketing agreement with Danish firm Vivostat, marking a recent collaboration. Under the new alliance, TRB Chemedica UK will introduce ArthroZheal to the U.K. and Ireland.
- In December 2022, Integra LifeSciences Holdings Corporation, a top-tier medical technology company with a global reach, announced the successful completion of its acquisition of Surgical Innovation Associates (SIA), a Chicago-based company that focuses on revolutionary medical devices for plastic surgery.
- In April 2022, Ethicon, part of Johnson & Johnson MedTech companies, launched the Enseal X1 Straight Jaw Tissue Sealer, which enables a more robust and efficient sealing of tissue in various surgical procedures, while also providing easy access to specific target areas.
Why Purchase the Report?
- To visualize the global surgical glue market segmentation based on product type, application, end user and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of surgical glue market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as Excel consisting of key products of all the major players.
The global surgical glue market report would provide approximately 53 tables, 54 figures, and 195 Pages.
Target Audience 2023
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies